SARDH and neoplasm: In a model that more closely mimics the tumor microenvironment, where the proportion of tumor-reactive T cells in the peripheral blood is lower, we still observed that knocking down SARDH enhanced T-cell infiltration, as expected (Supplementary Fig. S6I, J).